A Phase 1 Dose Escalation and Cohort Expansion Study of TSR-042, an anti-PD-1 Monoclonal Antibody, in Patients with Advanced Solid Tumors

UCI-16-71
NCT02715284
Cancer - Cervix Uteri, Cancer - Corpus Uteri, Cancer - Other Female Genital, Cancer - Ovary
Krishnansu Tewari
Open
Treatment
I
Adult
Local

For information about cancer clinical trials at the UC Irvine Health Chao Family Comprehensive Cancer Center, call toll-free 877-UC-STUDY (877-827-8839) or email ucstudy@uci.edu.